Analysts' consensus shows Axonics performing as expected, with no major estimate changes post recent results. Despite a predicted slowdown in revenue growth, Axonics is still expected to outpace the wider industry.
Axonics' consistent revenue growth, despite last year's lack of profit, has led to a 33% annual increase in share price over the past five years, making it a potential investment opportunity.
Meghan Scanlon from Boston Scientific forecasts merger to enhance support for urologists handling chronic conditions. Acquisition may improve earnings per share over time, though GAAP earnings may see lesser increase due to related expenses.
Investors believe in Axonics' potential for future revenue growth, supporting higher stock prices despite a high P/S ratio. They discount the chance of a revenue decrease, but risks and other factors must also be considered.
Axonics' strong revenue growth may be driving its stock performance and could be attractive for growth investors. The recent sell-off may open up investment opportunities if long-term growth signs are positive.
アクソニクスに関するコメント
• $ブーズ アレン ハミルトン ホールディング A(BAH.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $ヒューマナ(HUM.US)$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB ハント トランスポート サービシズ(JBHT.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB ハント トランスポート サービシズ(JBHT.US)$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI インターナショナル A(CACI.US)$: Goldman Sachs Downgrad...
• $バンク オブ カリフォルニア(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $カレン フロスト バンカーズ(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $WW グレインジャー(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $インビテーション・ホームズ(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB バンコープ(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
- $コンソリデーテッド コミュニケーションズ ホールディングス(CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $ボイジャー セラピューティクス(VYGR.US)$ +12.2%: agrees to licensing option with $ノバルティス(NVS.US)$; Voyager receives $54 million upfront.
- $エイゴン(AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $エーゼットゼット(AZZ.US)$ +...
まだコメントはありません